Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy... Gastric Cancer (2017) 20:825–833 DOI 10.1007/s10120-016-0681-6 ORIGINAL ARTICLE Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 1 2 3 1 • • • • Valentina Fanotto Stefano Cordio Giulia Pasquini Caterina Fontanella 4 5 6 7 • • • • Lorenza Rimassa Francesco Leone Gerardo Rosati Daniele Santini 8 9 10 • • • Riccardo Giampieri Samantha Di Donato Gianluca Tomasello 11 12 13 • • • Nicola Silvestris Filippo Pietrantonio Francesca Battaglin 14 15 16 • • • Antonio Avallone Mario Scartozzi Eufemia Stefania Lutrino 17 18 19 20 • • • • Davide Melisi Lorenzo Antonuzzo Antonio Pellegrino Valter Torri Giuseppe Aprile Received: 31 August 2016 / Accepted: 8 December 2016 / Published online: 27 December 2016 The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2016 Abstract used to describe categorical features. To predict the impact Background Although second-line therapy is often con- of clinical variables on progression-free survival and sidered for advanced gastric cancer patients, the optimal overall survival, Kaplan–Meier and Cox regression analy- candidates are not well defined. ses were performed. Methods We retrospectively collected baseline parameters, Results At the start of second-line therapy, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Gastric Cancer Springer Journals

Loading next page...
 
/lp/springer_journal/prognostic-factors-in-868-advanced-gastric-cancer-patients-treated-UhaOmdYfRd
Publisher
Springer Journals
Copyright
Copyright © 2016 by The International Gastric Cancer Association and The Japanese Gastric Cancer Association
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Abdominal Surgery; Gastroenterology; Cancer Research
ISSN
1436-3291
eISSN
1436-3305
D.O.I.
10.1007/s10120-016-0681-6
Publisher site
See Article on Publisher Site

Abstract

Gastric Cancer (2017) 20:825–833 DOI 10.1007/s10120-016-0681-6 ORIGINAL ARTICLE Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 1 2 3 1 • • • • Valentina Fanotto Stefano Cordio Giulia Pasquini Caterina Fontanella 4 5 6 7 • • • • Lorenza Rimassa Francesco Leone Gerardo Rosati Daniele Santini 8 9 10 • • • Riccardo Giampieri Samantha Di Donato Gianluca Tomasello 11 12 13 • • • Nicola Silvestris Filippo Pietrantonio Francesca Battaglin 14 15 16 • • • Antonio Avallone Mario Scartozzi Eufemia Stefania Lutrino 17 18 19 20 • • • • Davide Melisi Lorenzo Antonuzzo Antonio Pellegrino Valter Torri Giuseppe Aprile Received: 31 August 2016 / Accepted: 8 December 2016 / Published online: 27 December 2016 The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2016 Abstract used to describe categorical features. To predict the impact Background Although second-line therapy is often con- of clinical variables on progression-free survival and sidered for advanced gastric cancer patients, the optimal overall survival, Kaplan–Meier and Cox regression analy- candidates are not well defined. ses were performed. Methods We retrospectively collected baseline parameters, Results At the start of second-line therapy,

Journal

Gastric CancerSpringer Journals

Published: Dec 27, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off